SMI
11.657,46
PKT
-134,45
PKT
-1,14
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.05.12 | Zurich Insurance buy | Vontobel Research | |
11.05.12 | UBS buy | Vontobel Research | |
11.05.12 | UBS hold | Vontobel Research | |
10.05.12 | Zurich Insurance neutral | Sarasin Research | |
10.05.12 | Holcim hold | Société Générale Group S.A. (SG) | |
10.05.12 | Holcim hold | Vontobel Research | |
10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
10.05.12 | Zurich Insurance buy | Vontobel Research | |
10.05.12 | Holcim neutral | Sarasin Research | |
09.05.12 | Holcim hold | Vontobel Research | |
09.05.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
08.05.12 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
08.05.12 | Nestlé overweight | Morgan Stanley | |
08.05.12 | Swiss Life buy | Sarasin Research | |
08.05.12 | Lonza kaufen | Die Actien-Börse | |
08.05.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
08.05.12 | Swiss Life buy | Vontobel Research | |
07.05.12 | Swiss Re underperform | RBC Capital Markets | |
07.05.12 | Swiss Re kaufen | Hamburger Sparkasse AG (Haspa) | |
07.05.12 | Lonza hold | Vontobel Research | |
07.05.12 | Swiss Re buy | Vontobel Research | |
07.05.12 | Holcim hold | Société Générale Group S.A. (SG) | |
04.05.12 | Swiss Re add | Commerzbank Corp. & Markets | |
04.05.12 | UBS buy | Nomura | |
04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
04.05.12 | Novartis buy | UBS AG | |
04.05.12 | Swiss Re buy | Sarasin Research | |
04.05.12 | Lonza neutral | Sarasin Research | |
04.05.12 | Lonza underperform | Cheuvreux SA | |
04.05.12 | Swiss Re underperform | Cheuvreux SA | |
04.05.12 | Holcim hold | Vontobel Research | |
04.05.12 | Lonza hold | Vontobel Research | |
04.05.12 | Swiss Re buy | Vontobel Research | |
03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
07.05.12 | UBS outperform | RBC Capital Markets | |
03.05.12 | Swisscom outperform | Exane-BNP Paribas SA | |
03.05.12 | UBS hold | Deutsche Bank AG | |
03.05.12 | UBS overweight | Morgan Stanley | |
03.05.12 | UBS underperform | Exane-BNP Paribas SA | |
03.05.12 | UBS neutral | Banc of America Securities-Merrill Lynch |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.